Suppr超能文献

胃癌趋势:日本 35 年的外科手术经验。

Trend in gastric cancer: 35 years of surgical experience in Japan.

机构信息

Department of Surgery, Kitasato University School of Medicine, Kitasato 1-15-1, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan.

出版信息

World J Gastroenterol. 2011 Aug 7;17(29):3390-7. doi: 10.3748/wjg.v17.i29.3390.

Abstract

AIM

To investigate the trend in gastric cancer surgery in the context of rapid therapeutic advancement in Japan and East Asia.

METHODS

A retrospective analysis was performed on 4163 patients who underwent gastric resection for gastric cancer with histological confirmation between 1971 and 2007 at the surgical unit in Kitasato University Hospital, to determine the trend in gastric cancer requiring surgery.

RESULTS

Gastric cancer requiring surgical resection increased in our hospital, but the incidence adjusted for population was constant during the observed period. Interestingly, the ratio of diffuse type/intestinal type gastric cancer was unexpectedly unchanged, and that of advanced/early gastric cancer (EGC) was, however, markedly reduced, while the actual incidence of potentially curative advanced gastric cancer tended to decrease. The incidence of EGC requiring surgery tended to increase as a whole, which is consistent with increased prevalence of endoscopic surveillance. As a result, overall survival and mortality of gastric cancer requiring gastric resection has recently markedly improved.

CONCLUSION

In Japan, planned interventions may improve surgical gastric cancer mortality, but an unexpected trend of persistent existence of intestinal type cancer suggests the need for more robust medical intervention.

摘要

目的

探讨在日本和东亚地区快速治疗进展的背景下胃癌手术的趋势。

方法

对 1971 年至 2007 年间在北里大学医院外科进行组织学确认的 4163 例接受胃癌胃切除术的患者进行回顾性分析,以确定需要手术的胃癌趋势。

结果

我院需要手术治疗的胃癌患者有所增加,但在观察期间,按人口调整的发病率保持不变。有趣的是,弥漫型/肠型胃癌的比例出人意料地没有变化,而晚期/早期胃癌(EGC)的比例明显下降,而潜在可治愈的晚期胃癌的实际发病率则呈下降趋势。需要手术治疗的 EGC 的发生率总体呈上升趋势,这与内镜监测的普及有关。结果,最近需要进行胃切除术的胃癌的总生存率和死亡率明显提高。

结论

在日本,有计划的干预措施可能会改善胃癌手术死亡率,但肠型癌症持续存在的意外趋势表明需要更有力的医疗干预。

相似文献

1
Trend in gastric cancer: 35 years of surgical experience in Japan.
World J Gastroenterol. 2011 Aug 7;17(29):3390-7. doi: 10.3748/wjg.v17.i29.3390.
2
Early gastric cancer.
Ann Surg. 1984 May;199(5):604-9. doi: 10.1097/00000658-198405000-00016.
3
Modern treatment of early gastric cancer: review of the Japanese experience.
Dig Surg. 2002;19(5):333-9. doi: 10.1159/000065829.
4
Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.
Br J Cancer. 2000 Oct;83(8):986-91. doi: 10.1054/bjoc.2000.1427.
6
Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival.
Langenbecks Arch Surg. 2005 Aug;390(4):286-93. doi: 10.1007/s00423-004-0482-y. Epub 2004 Apr 30.
9
Management and associated factors of delayed perforation after gastric endoscopic submucosal dissection.
World J Gastroenterol. 2015 Nov 28;21(44):12635-43. doi: 10.3748/wjg.v21.i44.12635.
10
Current status and future perspectives in gastric cancer management.
Cancer Treat Rev. 2000 Aug;26(4):243-55. doi: 10.1053/ctrv.2000.0164.

引用本文的文献

5
Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study.
World J Gastroenterol. 2022 Jan 21;28(3):381-398. doi: 10.3748/wjg.v28.i3.381.
6
Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model.
Gastric Cancer. 2022 Jan;25(1):96-106. doi: 10.1007/s10120-021-01229-x. Epub 2021 Aug 9.
7
Endoscopic Resection of Undifferentiated-type Early Gastric Cancer.
J Gastric Cancer. 2020 Dec;20(4):345-354. doi: 10.5230/jgc.2020.20.e37. Epub 2020 Dec 24.
8
Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China.
World J Gastrointest Oncol. 2020 Oct 15;12(10):1119-1132. doi: 10.4251/wjgo.v12.i10.1119.
9
Astragalus Polysaccharide Promotes Adriamycin-Induced Apoptosis in Gastric Cancer Cells.
Cancer Manag Res. 2020 Apr 1;12:2405-2414. doi: 10.2147/CMAR.S237146. eCollection 2020.

本文引用的文献

1
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
Lancet Oncol. 2009 Nov;10(11):1063-9. doi: 10.1016/S1470-2045(09)70259-1. Epub 2009 Oct 7.
2
Epidemiology and clinical characteristics of GERD in the Japanese population.
J Gastroenterol. 2009;44(6):518-34. doi: 10.1007/s00535-009-0047-5. Epub 2009 Apr 14.
4
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
Lancet Oncol. 2008 Mar;9(3):215-21. doi: 10.1016/S1470-2045(08)70035-4. Epub 2008 Feb 20.
5
Cancer of the gastric stump following distal gastrectomy for cancer.
Br J Surg. 2007 Jan;94(1):92-5. doi: 10.1002/bjs.5538.
6
Epidemiology of gastric cancer.
World J Gastroenterol. 2006 Jan 21;12(3):354-62. doi: 10.3748/wjg.v12.i3.354.
7
Global cancer statistics, 2002.
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
8
International variation.
Oncogene. 2004 Aug 23;23(38):6329-40. doi: 10.1038/sj.onc.1207726.
9
Prospective cohort study of comprehensive prevention to gastric cancer.
World J Gastroenterol. 2003 Mar;9(3):432-6. doi: 10.3748/wjg.v9.i3.432.
10
Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan.
J Infect Dis. 2002 Dec 1;186(11):1621-30. doi: 10.1086/345374. Epub 2002 Nov 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验